1 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 10 of 330 | 4270 prescriptions Less than 1% of all prescriptions | 3270 | 900 patients 18% of all patients | 650 patients 13% of all patients | |
2 MONTELUKAST SODIUM | 20 of 280 | 2100 prescriptions Less than 1% of all prescriptions | 1280 | 490 patients 10% of all patients | 370 patients 7% of all patients | |
3 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 20 of 330 | 2790 prescriptions Less than 1% of all prescriptions | 2240 | 720 patients 14% of all patients | 590 patients 12% of all patients | |
4 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 30 of 360 | 2900 prescriptions Less than 1% of all prescriptions | 2340 | 560 patients 11% of all patients | 450 patients 9% of all patients | |
5 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 20 of 350 | 2800 prescriptions Less than 1% of all prescriptions | 2180 | 650 patients 13% of all patients | 490 patients 10% of all patients | |
6 SPIRIVA (TIOTROPIUM BROMIDE) | 20 of 350 | 1970 prescriptions Less than 1% of all prescriptions | 1690 | 370 patients 7% of all patients | < 11 | |
7 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 70 of 310 | 2060 prescriptions Less than 1% of all prescriptions | | 390 patients 8% of all patients | < 11 | |
8 VENTOLIN HFA (ALBUTEROL SULFATE) | 30 of 360 | 2610 prescriptions Less than 1% of all prescriptions | 1950 | 940 patients 19% of all patients | 710 patients 14% of all patients | |
9 PREDNISONE | 30 of 370 | 3370 prescriptions Less than 1% of all prescriptions | 2670 | 1830 patients 36% of all patients | 1430 patients 28% of all patients | |
10 PROAIR HFA (ALBUTEROL SULFATE) | 20 of 320 | 2110 prescriptions Less than 1% of all prescriptions | 1440 | 710 patients 14% of all patients | 540 patients 11% of all patients | |
11 AZITHROMYCIN | 10 of 370 | 1920 prescriptions Less than 1% of all prescriptions | 1500 | 830 patients 16% of all patients | 690 patients 14% of all patients | A |
12 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 30 of 210 | 840 prescriptions Less than 1% of all prescriptions | 710 | 200 patients 4% of all patients | < 11 | |
13 DALIRESP (ROFLUMILAST) | 30 of 190 | 820 prescriptions Less than 1% of all prescriptions | | 160 patients 3% of all patients | < 11 | |
14 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 80 of 280 | 630 prescriptions Less than 1% of all prescriptions | 450 | 200 patients 4% of all patients | < 11 | |
15 FLUTICASONE PROPIONATE | 40 of 260 | 610 prescriptions Less than 1% of all prescriptions | 260 | 190 patients 4% of all patients | < 11 | |
16 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 40 of 140 | 450 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 FLOVENT HFA (FLUTICASONE PROPIONATE) | 70 of 170 | 340 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 ALVESCO (CICLESONIDE) | 10 of 20 | 360 prescriptions Less than 1% of all prescriptions | 360 | < 11 | < 11 | |
19 RANITIDINE HCL | 60 of 110 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 50 of 150 | 400 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 OMEPRAZOLE | 110 of 180 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 ESBRIET (PIRFENIDONE) | 20 of 60 | 320 prescriptions Less than 1% of all prescriptions | 320 | < 11 | < 11 | |
23 FAMOTIDINE | 20 of 30 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 FLOVENT DISKUS (FLUTICASONE PROPIONATE) | 10 of 30 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 80 of 220 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 100 of 180 | 220 prescriptions Less than 1% of all prescriptions | | 110 patients 2% of all patients | < 11 | |
27 PROVENTIL HFA (ALBUTEROL SULFATE) | 10 of 40 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 ARALAST NP (ALPHA-1-PROTEINASE INHIBITOR) | 10 | 220 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
29 LEVALBUTEROL TARTRATE HFA (LEVALBUTEROL TARTRATE) | 10 of 40 | 250 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
30 ETHAMBUTOL HCL | 10 of 30 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
31 PROLASTIN C (ALPHA-1-PROTEINASE INHIBITOR) | 10 of 20 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
32 IPRATROPIUM BROMIDE | 90 of 110 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
33 MOMETASONE FUROATE | 20 of 20 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
34 XOLAIR (OMALIZUMAB) | 10 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
35 CREON (LIPASE/PROTEASE/AMYLASE) | 30 of 30 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
36 CHANTIX (VARENICLINE TARTRATE) | 60 of 70 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
37 AZELASTINE HCL | 50 of 70 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
38 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 30 of 70 | 240 prescriptions Less than 1% of all prescriptions | | 230 patients 5% of all patients | < 11 | A |
39 SODIUM CHLORIDE (SODIUM CHLORIDE IRRIG SOLUTION) | 10 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
40 EPINEPHRINE | 10 | 120 prescriptions Less than 1% of all prescriptions | | 110 patients 2% of all patients | < 11 | |